These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4743367)

  • 1. Activity increase associated with obesity induced by monosodium glutamate in mice.
    Araujo PE; Mayer J
    Am J Physiol; 1973 Oct; 225(4):764-5. PubMed ID: 4743367
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity.
    Poon TK; Cameron DP
    Am J Physiol; 1978 May; 234(5):E532-4. PubMed ID: 645905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity in exercising, hypophagic rats treated with monosodium glutamate.
    Nikoletseas MM
    Physiol Behav; 1977 Dec; 19(6):767-73. PubMed ID: 565061
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of gold-thioglucose and monosodium glutamate to induce obesity in mice.
    Djazayery A; Miller DS
    Proc Nutr Soc; 1973 May; 32(1):30A-31A. PubMed ID: 4586579
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse.
    Lorden JF; Caudle A
    Neurobehav Toxicol Teratol; 1986; 8(5):509-19. PubMed ID: 3785512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.
    Olney JW
    Science; 1969 May; 164(3880):719-21. PubMed ID: 5778021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Monosodium L-glutamate (MSG) syndrome in mice develops independently of housing condition.
    Barnhart JE; Pizzi WJ
    Neurobehav Toxicol Teratol; 1982; 4(5):549-56. PubMed ID: 7177307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral changes in adult rats treated with monosodium glutamate in the neonatal stage.
    Pradhan SN; Lynch JF
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):301-4. PubMed ID: 5031140
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenalectomy prevents obesity in glutamate-treated mice.
    Tokuyama K; Himms-Hagen J
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E139-44. PubMed ID: 2764098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monosodium glutamate-induced changes of aggression and open-field activity in rats.
    Carter LT; Levesque L
    Neurobehav Toxicol; 1979; 1(4):247-51. PubMed ID: 575996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Depletion of Rough Endoplasmic Reticulum in Epithelial Cells of the Small Intestine in Monosodium Glutamate Mice Model of Obesity.
    Nakadate K; Motojima K; Hirakawa T; Tanaka-Nakadate S
    Biomed Res Int; 2016; 2016():5251738. PubMed ID: 27437400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of monosodium glutamate on the early biochemical and behavioral development of the rat.
    Berry HK; Butcher RE; Elliot LA; Brunner RL
    Dev Psychobiol; 1974 Mar; 7(2):165-73. PubMed ID: 4822849
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity induced by monosodium glutamate in mice.
    Matsuyama S; Oki Y; Yokoki Y
    Natl Inst Anim Health Q (Tokyo); 1973; 13(2):91-101. PubMed ID: 4792405
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular functions of mature mice following neonatal monosodium glutamate.
    Prabhu VG; Oester YT
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):59-71. PubMed ID: 5130153
    [No Abstract]   [Full Text] [Related]  

  • 15. Brown adipose tissue thermogenesis, torpor, and obesity of glutamate-treated mice.
    Tokuyama K; Himms-Hagen J
    Am J Physiol; 1986 Oct; 251(4 Pt 1):E407-15. PubMed ID: 2876642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats.
    Franco CCS; Prates KV; Previate C; Moraes AMP; Matiusso CCI; Miranda RA; de Oliveira JC; Tófolo LP; Martins IP; Barella LF; Ribeiro TA; Malta A; Pavanello A; Francisco FA; Gomes RM; Alves VS; Moreira VM; Rigo KP; Almeida DL; de Sant Anna JR; Prado MAAC; Mathias PCF
    Endocrine; 2017 May; 56(2):346-356. PubMed ID: 28233096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
    Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vagotomy reduces obesity in MSG-treated rats.
    Balbo SL; Mathias PC; Bonfleur ML; Alves HF; Siroti FJ; Monteiro OG; Ribeiro FB; Souza AC
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):291-6. PubMed ID: 11958282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
    Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L
    J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cytochrome P450 activities and expression levels in the liver and intestines of the monosodium glutamate-induced mouse model of human obesity.
    Tomankova V; Liskova B; Skalova L; Bartikova H; Bousova I; Jourova L; Anzenbacher P; Ulrichova J; Anzenbacherova E
    Life Sci; 2015 Jul; 133():15-20. PubMed ID: 25998026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.